CNSX:BE Beleave (BE) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Beleave Stock (CNSX:BE) 30 days 90 days 365 days Advanced Chart Remove Ads Get Beleave alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume777,666 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewBeleave Inc., together with its subsidiaries, cultivates, produces, and sells tetrahydrocannabinol and cannabidiol medical cannabis in Canada and Colombia. The company produces cannabis oils and extracts for medical purposes. It also operates a network of medical cannabis clinics under the Medi-Green banner. Beleave Inc. is headquartered in Hamilton, Canada.Read More… Remove Ads Receive BE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Beleave and its competitors with MarketBeat's FREE daily newsletter. Email Address BE Stock News HeadlinesFNNZF FinCanna Capital Corp.October 26, 2024 | seekingalpha.comBatman Arkham Knight: Ace Chemicals Infiltration Trailer Part 3!October 9, 2024 | msn.comTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 2, 2025 | Porter & Company (Ad)'Labour doesn't believe in free speech!' UK university sparks outrage after BANNING debate societyOctober 4, 2024 | msn.comTrump keeps warning about election 'cheating.' His Michigan supporters are ready to move onSeptember 28, 2024 | usatoday.comDead Rising 3 Gameplay (HD)August 29, 2024 | msn.comWhat we know (and don't) about Kamala Harris's economic planAugust 17, 2024 | msn.comRVVQF RavenQuest BioMed Inc.July 31, 2024 | seekingalpha.comSee More Headlines BE Stock Analysis - Frequently Asked Questions How do I buy shares of Beleave? Shares of BE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Beleave own? Based on aggregate information from My MarketBeat watchlists, some other companies that Beleave investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Canopy Growth (CGC), Montage Resources (MR), Arbutus Biopharma (ABUS), Aurora Cannabis (ACB) and Aurora Cannabis (ACBFF). Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Medicinals & Botanicals Sub-IndustryCannabis Current SymbolCNSX:BE CIKN/A WebN/A PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Unlock the Potential in Options TradingOptions trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.Get This Free Report This page (CNSX:BE) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWhy Elon Musk Is Investigating Fort KnoxWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beleave Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Beleave With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.